Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06841172 2025-08-01

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Phase 3 Recruiting

132 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT04175210 2025-07-25

PRART

Phase 3 Active not recruiting

400 enrolled

Breast

Breast Neoplasms

NCT06960707 2025-07-25

PRATO

Phase 3 Recruiting

400 enrolled

Breast

Breast Neoplasms

NCT05448547 2025-07-01

GrandP/SPCG19

Phase 3 Recruiting

980 enrolled

Genitourinary

Prostatic Neoplasms

NCT07020247 2025-06-13

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Phase 3 Recruiting

184 enrolled

Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Phase 3 Recruiting

852 enrolled

Radiation Injuries, Disease Progression

NCT02998385 2025-05-07

SANTAL

Phase 3 Active not recruiting

342 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT06946420 2025-04-27

SENECA

Phase 3 Active not recruiting

108 enrolled

Gastrointestinal

Radiation Therapy

NCT06855589 2025-03-04

PCS-XII

Phase 3 Not yet recruiting

400 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT04709380 2025-02-26

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Phase 3 Terminated

36 enrolled

Gastrointestinal

Radiotherapy

NCT06762405 2025-02-18

PREDIR-NEOREC

Phase 3 Recruiting

68 enrolled

GastrointestinalOther solid neoplasm

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

NCT00223171 2025-01-27

PCS IV

Phase 3 Active not recruiting

630 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

STABLE-MATES

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

RADVAN

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

HOPE

RePaIr-HN

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

NIRVANA-LUNG

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

BEFORE

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

OLIGAMI

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

BIOMEDE 2

ImproveCodel

LAP100

POLO

Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Randomized Study of Hypofractionated and Conventional Fractionation Radiotherapy After Breast Conservative Surgery

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Neo-Margin

Head and Neck Cancer Study Project in the Geriatric Population

FIL_GAZEBO

Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

TRAIN

UPFRONT-NECK

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

KANALRAD

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

PRART

PRATO

GrandP/SPCG19

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Omitting CTV for Primary Tumor in LS-SCLC

SANTAL

SENECA

PCS-XII

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

PREDIR-NEOREC

PCS IV